Retrospective study of carmustine or lomustine with bevacizumab in recurrent glioblastoma patients who have failed prior bevacizumab

BACKGROUND: Currently, there are no known effective treatments for recurrent glioblastoma once patients have progressed on a bevacizumab-containing regimen. We examined the efficacy of adding nitrosoureas to bevacizumab in patients who progressed while on an initial bevacizumab-containing regimen. M...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rahman, Rifaquat, Hempfling, Kelly, Norden, Andrew D., Reardon, David A., Nayak, Lakshmi, Rinne, Mikael L., Beroukhim, Rameen, Doherty, Lisa, Ruland, Sandra, Rai, Arun, Rifenburg, Jennifer, LaFrankie, Debra, Alexander, Brian M., Huang, Raymond Y., Wen, Patrick Y., Lee, Eudocia Q.
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2014
Materias:
Clinical Investigations
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4201074/
https://ncbi.nlm.nih.gov/pubmed/24958095
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou118
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares